The Experts below are selected from a list of 321 Experts worldwide ranked by ideXlab platform
Jon T. Mader - One of the best experts on this subject based on the ideXlab platform.
-
Short‐term Tympanostomy in conjunction with hyperbaric oxygen therapy
The Laryngoscope, 1998Co-Authors: Jeffrey T. Vrabec, Kelly S. Clements, Jon T. MaderAbstract:Objective: To determine the most effective method of short-term middle ear aeration in patients unable to tolerate hyperbaric oxygen (HBO) therapy. Study Design: Prospective study comparing two methods of short-term Tympanostomy in each patient. Methods: Seventeen adult patients were referred for management of barotitis and inability to tolerate hyperbaric oxygen therapy (HBO), Each patient underwent CO 2 laser Tympanostomy on the right ear and Tympanostomy with T-tube placement in the left ear. The tube was removed on completion of HBO. Patients were asked to rate pain and their satisfaction with each method of Tympanostomy using a visual analog scale. Otorrhea, persistent perforation, recurrent barotitis, hearing loss, and otalgia occurring during the study period were documented. Results: Laser Tympanostomy was associated with a significantly lower incidence of otorrhea but was attended by recurrent barotitis in four of 16 patients. Laser Tympanostomy was perceived as being less painful and was rated higher in overall satisfaction. Conclusions: Laser Tympanostomy is an effective method for management of barotitis in patients unable to tolerate HBO. Otorrhea is significantly reduced, although a risk of recurrent barotitis exists if the laser perforation closes prior to completion of HBO. Both methods of short-term Tympanostomy reduce complications when compared with a retrospective cohort.
-
Short-term Tympanostomy in conjunction with hyperbaric oxygen therapy.
The Laryngoscope, 1998Co-Authors: Jeffrey T. Vrabec, Kelly S. Clements, Jon T. MaderAbstract:To determine the most effective method of short-term middle ear aeration in patients unable to tolerate hyperbaric oxygen (HBO) therapy. Prospective study comparing two methods of short-term Tympanostomy in each patient. Seventeen adult patients were referred for management of barotitis and inability to tolerate hyperbaric oxygen therapy (HBO). Each patient underwent CO2 laser Tympanostomy on the right ear and Tympanostomy with T-tube placement in the left ear. The tube was removed on completion of HBO. Patients were asked to rate pain and their satisfaction with each method of Tympanostomy using a visual analog scale. Otorrhea, persistent perforation, recurrent barotitis, hearing loss, and otalgia occurring during the study period were documented. Laser Tympanostomy was associated with a significantly lower incidence of otorrhea but was attended by recurrent barotitis in four of 16 patients. Laser Tympanostomy was perceived as being less painful and was rated higher in overall satisfaction. Laser Tympanostomy is an effective method for management of barotitis in patients unable to tolerate HBO. Otorrhea is significantly reduced, although a risk of recurrent barotitis exists if the laser perforation closes prior to completion of HBO. Both methods of short-term Tympanostomy reduce complications when compared with a retrospective cohort.
Jeffrey T. Vrabec - One of the best experts on this subject based on the ideXlab platform.
-
Short‐term Tympanostomy in conjunction with hyperbaric oxygen therapy
The Laryngoscope, 1998Co-Authors: Jeffrey T. Vrabec, Kelly S. Clements, Jon T. MaderAbstract:Objective: To determine the most effective method of short-term middle ear aeration in patients unable to tolerate hyperbaric oxygen (HBO) therapy. Study Design: Prospective study comparing two methods of short-term Tympanostomy in each patient. Methods: Seventeen adult patients were referred for management of barotitis and inability to tolerate hyperbaric oxygen therapy (HBO), Each patient underwent CO 2 laser Tympanostomy on the right ear and Tympanostomy with T-tube placement in the left ear. The tube was removed on completion of HBO. Patients were asked to rate pain and their satisfaction with each method of Tympanostomy using a visual analog scale. Otorrhea, persistent perforation, recurrent barotitis, hearing loss, and otalgia occurring during the study period were documented. Results: Laser Tympanostomy was associated with a significantly lower incidence of otorrhea but was attended by recurrent barotitis in four of 16 patients. Laser Tympanostomy was perceived as being less painful and was rated higher in overall satisfaction. Conclusions: Laser Tympanostomy is an effective method for management of barotitis in patients unable to tolerate HBO. Otorrhea is significantly reduced, although a risk of recurrent barotitis exists if the laser perforation closes prior to completion of HBO. Both methods of short-term Tympanostomy reduce complications when compared with a retrospective cohort.
-
Short-term Tympanostomy in conjunction with hyperbaric oxygen therapy.
The Laryngoscope, 1998Co-Authors: Jeffrey T. Vrabec, Kelly S. Clements, Jon T. MaderAbstract:To determine the most effective method of short-term middle ear aeration in patients unable to tolerate hyperbaric oxygen (HBO) therapy. Prospective study comparing two methods of short-term Tympanostomy in each patient. Seventeen adult patients were referred for management of barotitis and inability to tolerate hyperbaric oxygen therapy (HBO). Each patient underwent CO2 laser Tympanostomy on the right ear and Tympanostomy with T-tube placement in the left ear. The tube was removed on completion of HBO. Patients were asked to rate pain and their satisfaction with each method of Tympanostomy using a visual analog scale. Otorrhea, persistent perforation, recurrent barotitis, hearing loss, and otalgia occurring during the study period were documented. Laser Tympanostomy was associated with a significantly lower incidence of otorrhea but was attended by recurrent barotitis in four of 16 patients. Laser Tympanostomy was perceived as being less painful and was rated higher in overall satisfaction. Laser Tympanostomy is an effective method for management of barotitis in patients unable to tolerate HBO. Otorrhea is significantly reduced, although a risk of recurrent barotitis exists if the laser perforation closes prior to completion of HBO. Both methods of short-term Tympanostomy reduce complications when compared with a retrospective cohort.
Richard N. Hubbell - One of the best experts on this subject based on the ideXlab platform.
-
Otorrhea after insertion of silver oxide-impregnated silastic Tympanostomy tubes.
Archives of otolaryngology--head & neck surgery, 1999Co-Authors: Christine G. Gourin, Richard N. HubbellAbstract:Background: Silver oxide-impregnated Tympanostomy tubes have been shown to decrease the incidence of postoperative otorrhea, but without a significant effect in the first postoperative week. Objective: To evaluate prospectively our results with silver oxide-impregnated Tympanostomy tubes and to identify factors associated with a higher incidence of early postoperative otorrhea. Design: Prospective nonrandomized study. Setting: University referral center. Patients and Other Participants: Six hundred thirty patients with chronic otitis media with effusion or recurrent otitis media. Interventions: Silver oxide-impregnated Silastic Tympanostomy tubes were inserted in 1254 ears. Subjects with mucoid or purulent effusions or blood at the myringotomy site at surgery were treated with topical antibiotic prophylaxis (sulfacetamide sodium-prednisolone acetate or neomycin sulfate-polymyxin B sulfate-hydrocortisone) for 5 days after Tympanostomy tube placement. Main Outcome Measures: Incidence of otorrhea after Tympanostomy tube insertion at 1 week and 1,3,6,9, and 12 months after surgery. Results: The overall incidence of postoperative otorrhea was 1.9%. The incidence of otorrhea in the first postoperative week was 5.6%; the incidence of otorrhea after the first postoperative week was 1.2% (P
Kelly S. Clements - One of the best experts on this subject based on the ideXlab platform.
-
Short‐term Tympanostomy in conjunction with hyperbaric oxygen therapy
The Laryngoscope, 1998Co-Authors: Jeffrey T. Vrabec, Kelly S. Clements, Jon T. MaderAbstract:Objective: To determine the most effective method of short-term middle ear aeration in patients unable to tolerate hyperbaric oxygen (HBO) therapy. Study Design: Prospective study comparing two methods of short-term Tympanostomy in each patient. Methods: Seventeen adult patients were referred for management of barotitis and inability to tolerate hyperbaric oxygen therapy (HBO), Each patient underwent CO 2 laser Tympanostomy on the right ear and Tympanostomy with T-tube placement in the left ear. The tube was removed on completion of HBO. Patients were asked to rate pain and their satisfaction with each method of Tympanostomy using a visual analog scale. Otorrhea, persistent perforation, recurrent barotitis, hearing loss, and otalgia occurring during the study period were documented. Results: Laser Tympanostomy was associated with a significantly lower incidence of otorrhea but was attended by recurrent barotitis in four of 16 patients. Laser Tympanostomy was perceived as being less painful and was rated higher in overall satisfaction. Conclusions: Laser Tympanostomy is an effective method for management of barotitis in patients unable to tolerate HBO. Otorrhea is significantly reduced, although a risk of recurrent barotitis exists if the laser perforation closes prior to completion of HBO. Both methods of short-term Tympanostomy reduce complications when compared with a retrospective cohort.
-
Short-term Tympanostomy in conjunction with hyperbaric oxygen therapy.
The Laryngoscope, 1998Co-Authors: Jeffrey T. Vrabec, Kelly S. Clements, Jon T. MaderAbstract:To determine the most effective method of short-term middle ear aeration in patients unable to tolerate hyperbaric oxygen (HBO) therapy. Prospective study comparing two methods of short-term Tympanostomy in each patient. Seventeen adult patients were referred for management of barotitis and inability to tolerate hyperbaric oxygen therapy (HBO). Each patient underwent CO2 laser Tympanostomy on the right ear and Tympanostomy with T-tube placement in the left ear. The tube was removed on completion of HBO. Patients were asked to rate pain and their satisfaction with each method of Tympanostomy using a visual analog scale. Otorrhea, persistent perforation, recurrent barotitis, hearing loss, and otalgia occurring during the study period were documented. Laser Tympanostomy was associated with a significantly lower incidence of otorrhea but was attended by recurrent barotitis in four of 16 patients. Laser Tympanostomy was perceived as being less painful and was rated higher in overall satisfaction. Laser Tympanostomy is an effective method for management of barotitis in patients unable to tolerate HBO. Otorrhea is significantly reduced, although a risk of recurrent barotitis exists if the laser perforation closes prior to completion of HBO. Both methods of short-term Tympanostomy reduce complications when compared with a retrospective cohort.
Walter M. Belenky - One of the best experts on this subject based on the ideXlab platform.
-
Phenylephrine and the Prevention of Postoperative Tympanostomy Tube Obstruction
Archives of otolaryngology--head & neck surgery, 1998Co-Authors: Jerald S. Altman, Michael Haupert, Ronda A. Hamaker, Walter M. BelenkyAbstract:Objective To determine the efficacy of phenylephrine hydrochloride, a topical vasoconstrictor, in preventing Tympanostomy tube obstruction. Design Prospective, randomized, double-blind, controlled trial of patients undergoing myringotomy with Tympanostomy tube insertion. Setting Academic, tertiary referral medical center. Patients Two hundred eight patients were enrolled in the study; 157 patients (310 ears) returned for postoperative evaluation. Interventions Myringotomy with Tympanostomy tube insertion was performed in all ears: 139 control ears received ototopical antibiotics and 171 treatment ears received ototopical antibiotics plus topical phenylephrine. Main Outcome Measure Postoperative Tympanostomy tube obstruction. Results The overall incidence of Tympanostomy tube obstruction was 5.2%: 8.6% in the control group and 2.3% in the treatment group. The treatment group demonstrated an odds ratio of 0.25 (95% confidence interval, 0.08-0.78; P =.02). Conclusion The use of phenylephrine following Tympanostomy tube insertion greatly reduces the incidence of tube obstruction.
